EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Serum occludin as a novel biomarker in adult atopic dermatitis: a pilot case-control study

Sheron Tune Jawahar, Manonmoney Jayaraman, Priyatharsini Thamaraiselvan, Kakithakara Vajravelu Leela

Exploration of Immunology · 11.03.2026 · 6

DOI: 10.37349/ei.2026.1003239 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Exploration of Immunology, online erschienen am 11.03.2026. Verfasst von Sheron Tune Jawahar und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis is a chronic inflammatory skin condition characterized by immune dysregulation and dysfunction of the epidermal barrier. Although occludin, a vital tight junction protein, is essential for preserving barrier integrity, very little is known about its potential as a serum biomarker in atopic dermatitis. This pilot case-control study measured serum occludin levels in 30 adult atopic dermatitis patients and 30 age- and sex-matched healthy controls between May and August 2025, using a commercially available sandwich enzyme-linked immunosorbent assay (ELISA) kit. Findings showed serum occludin levels were significantly higher in atopic dermatitis patients (mean: 2.50 ± 1.10 ng/mL) compared to healthy controls (mean: 0.68 ± 0.69 ng/mL; p < 0.001), with levels showing a decreasing trend with age. Serum occludin exhibited high diagnostic performance [area under the curve (AUC) = 0.92] and represents a sensitive and specific, non-invasive biomarker for atopic dermatitis. These preliminary findings lay the groundwork for future studies exploring serum occludin as a potential biomarker for atopic dermatitis assessment.

Zitieren

APA

Jawahar, S. T., Jayaraman, M., Thamaraiselvan, P., & Leela, K. V. (2026). Serum occludin as a novel biomarker in adult atopic dermatitis: a pilot case-control study. Exploration of Immunology, 6. https://doi.org/10.37349/ei.2026.1003239

Vancouver

Jawahar ST, Jayaraman M, Thamaraiselvan P, Leela KV. Serum occludin as a novel biomarker in adult atopic dermatitis: a pilot case-control study. Exploration of Immunology. 2026;6. doi:10.37349/ei.2026.1003239

BibTeX
@article{Jawahar2026,
  author = {Jawahar, Sheron Tune and Jayaraman, Manonmoney and Thamaraiselvan, Priyatharsini and Leela, Kakithakara Vajravelu},
  title = {Serum occludin as a novel biomarker in adult atopic dermatitis: a pilot case-control study},
  journal = {Exploration of Immunology},
  year = {2026},
  volume = {6},
  doi = {10.37349/ei.2026.1003239}
}
Kostenlos starten →